Premium
Prescribing outside of a drug's licence: issues and implications
Author(s) -
Chisholm Alison
Publication year - 2013
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1036
Subject(s) - medicine , bevacizumab , drug , focus (optics) , family medicine , pharmacology , surgery , physics , chemotherapy , optics
The GMC recently published updated guidance on prescribing outside of a medication's licence. Here, we examine the drivers and implications for off‐label prescribing, with a particular focus on the issues surrounding the prescribing of bevacizumab in wet AMD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom